• Kazam
  • AIFA Grants
  • Information for health professionals
  • Kazam
  • Online anaphylaxis training
  • 5 things to question

  • National Allergy Strategy - KABAM survey opens
    Oct 5, 2016:  The National Allergy Strategy Knowledge and Barriers to Allergy Management (KABAM) survey for teens and young adults will be available from 5th October – 3 November 2016. This survey is for people aged 12-24 years old with severe allergy. The survey is being conducted to enable the National Allergy Strategy to collect i...
  • ASCIA 2016 Conference Report
    Sep 21, 2016:  The ASCIA 2016 conference provided more than 600 delegates with a unique opportunity to hear from 6 international experts and more than 30 local experts on a wide range of areas in allergy and clinical immunology. The conference also included 79 posters, 48 poster presentations and 16 clinical grand rounds presentations...
  • AIFA seed funding leads to NHMRC grant
    Aug 23, 2016:  We are proud to announce that the AusPollen project has been awarded $626,442 in the latest round of NHMRC Partnership Project grants with a further $653,129 in partner organisation in kind and cash support. AusPollen, the Australian Pollen Allergen Partnership, will build, implement and evaluate the first standardised ...
  • Updated ASCIA Action Plans for Anaphylaxis and Allergic Reactions
    Aug 10, 2016:  ASCIA has released updated Action Plans for Anaphylaxis and Allergic Reactions on its website: www.allergy.org.au/health-professionals/anaphylaxis-resources/ascia-action-plan-for-anaphylaxis The main changes are an increased emphasis of key messages, inclusion of images to show how to position a person with anaphylaxi...
  • ASCIA 2016 Conference – registration and abstract submission is now open
    May 25, 2016:  It is a pleasure to advise that the ASCIA 2016 Conference website now has available:  conference program;  discounted earlybird registration until 15 July 2016;  abstract submission open until 18 July 2016;  accommodation booking.  Quick links to key pages:  Conference progra...
  • ASCIA releases guidelines for infant feeding and allergy prevention
    May 18, 2016: ASCIA Guidelines for infant feeding and allergy prevention and information on how to introduce solid foods to infants have been released on the ASCIA website: www.allergy.org.au/patients/allergy-prevention  These guidelines provide parents and health professionals with advice and recommendations relevant to...
  • Federal Government announces funding of $500k for National Allergy Strategy implementation
    May 16, 2016:  It is with great pleasure that we confirm that the federal government's funding of $500k for National Allergy Strategy implementation was announced at the launch of Food Allergy Week in Sydney on 16 May 2016, by the Minister for Health, the Hon Sussan Ley MP. The National Allergy Strategy was launched in...
  • Updated information regarding the status of allergen shortages in Australia and New Zealand
    May 2, 2016:  ASCIA was officially advised on April 29 that there is a preventive recall of the Inmunotek brand of subcutaneous (injectable) immunotherapy allergen extracts that are supplied by Australasian Medical and Scientific Limited (AMSL). This preventive recall means that shipping of these products from the AMSL warehouses is c...
  • Changes to adrenaline autoinjector labels
    Apr 19 2016:  In Australia, adrenaline is the approved name of the ingredient in autoinjector devices used for the emergency treatment of anaphylaxis. Currently, the only available autoinjector to treat anaphylaxis in Australia and New Zealand is supplied under the brand name EpiPen®. In some countries, including the USA, adrenaline i...
ASCIA is a WAO member society

ASCIA is a WAO member society
Follow ASCIA

ASCIA on facebookASCIA on TwitterASCIA on YouTube

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...


Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.


This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health

Verify here.